Kura Oncology Stock Price - KURA

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
After Hours
Last Trade
Last: $ 16.44 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.17 -1.02% 16.44 16.92 16.39 16.63 16.61 16:59:50
Bid Price Ask Price Spread Spread % News
15.88 18.50 2.62 14.16% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,634 117,667 $ 16.62 $ 1,955,728 197,254 10.20 - 21.50
Last Trade Time Type Quantity Stock Price Currency
16:07:36 average 457 $ 16.44 USD

Kura Oncology Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 743.33M 45.21M $ -60.45M -1.73 - 44.85M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Kura Oncology News

Date Time Source News Article
9/16/201906:30GlobeNewswire Inc.Kura Oncology Doses First Patient in Phase 1 Clinical Trial..
9/03/201907:03Edgar (US Regulatory)Current Report Filing (8-k)
9/03/201906:30GlobeNewswire Inc.Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib..
8/29/201906:30GlobeNewswire Inc.Kura Oncology to Participate in Two Upcoming Investor..
8/29/201905:00Edgar (US Regulatory)Notice of Effectiveness (effect)
8/28/201916:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/21/201915:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)

Latest KURA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KURA Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week16.4416.9215.8516.3657119k0-
1 Month16.9216.9414.9315.8076197k-0.48-2.84%
3 Months19.421.514.9318.6675276k-2.96-15.26%
6 Months16.0121.514.4517.8724269k0.432.69%
1 Year16.721.510.216.0733252k-0.26-1.56%
3 Years7.0724.025415.0828250k9.37132.53%
5 Years8.7124.0252.513.8705220k7.7388.75%

Kura Oncology Description

Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through United States.
Your Recent History
NASDAQ
KURA
Kura Oncol..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190920 04:18:17